Elizabeth Anderson
Stock Analyst at Evercore ISI Group
(2.40)
# 2,406
Out of 5,113 analysts
134
Total ratings
51.81%
Success rate
-2.52%
Average return
Main Sectors:
Stocks Rated by Elizabeth Anderson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRVA Privia Health Group | Maintains: Outperform | $28 → $30 | $23.64 | +26.90% | 5 | Nov 7, 2025 | |
| OMDA Omada Health | Maintains: Outperform | $27 → $28 | $14.50 | +93.10% | 1 | Nov 7, 2025 | |
| DOCS Doximity | Maintains: Outperform | $81 → $70 | $43.65 | +60.37% | 10 | Nov 7, 2025 | |
| HSIC Henry Schein | Maintains: Outperform | $83 → $90 | $77.35 | +16.35% | 2 | Nov 5, 2025 | |
| CAH Cardinal Health | Maintains: Outperform | $190 → $220 | $202.95 | +8.40% | 10 | Oct 31, 2025 | |
| TDOC Teladoc Health | Maintains: In-Line | $9 → $8 | $7.23 | +10.65% | 6 | Oct 30, 2025 | |
| CVS CVS Health | Maintains: Outperform | $85 → $95 | $77.72 | +22.23% | 10 | Oct 30, 2025 | |
| ALGN Align Technology | Maintains: Outperform | $160 → $170 | $157.69 | +7.81% | 15 | Oct 30, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: In-Line | $17 → $13 | $11.21 | +15.97% | 8 | Oct 8, 2025 | |
| IQV IQVIA Holdings | Maintains: Outperform | $220 → $240 | $220.69 | +8.75% | 7 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $60 → $65 | $47.25 | +37.57% | 2 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $4 → $3 | $2.35 | +27.66% | 9 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $7 → $11 | $17.74 | -37.99% | 10 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $185 → $190 | $176.06 | +7.92% | 4 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $300 → $305 | $252.03 | +21.02% | 7 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $800 → $825 | $820.25 | +0.58% | 7 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $19 → $23 | $22.28 | +3.23% | 4 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $5 → $3 | $0.73 | +308.44% | 5 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $32 → $36 | $32.84 | +9.62% | 4 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $68 → $26 | $2.33 | +1,026.61% | 3 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: In-Line | $35 → $15 | $4.37 | +243.25% | 3 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: In-Line | $11 | $1.33 | +727.07% | 2 | Jan 4, 2022 |
Privia Health Group
Nov 7, 2025
Maintains: Outperform
Price Target: $28 → $30
Current: $23.64
Upside: +26.90%
Omada Health
Nov 7, 2025
Maintains: Outperform
Price Target: $27 → $28
Current: $14.50
Upside: +93.10%
Doximity
Nov 7, 2025
Maintains: Outperform
Price Target: $81 → $70
Current: $43.65
Upside: +60.37%
Henry Schein
Nov 5, 2025
Maintains: Outperform
Price Target: $83 → $90
Current: $77.35
Upside: +16.35%
Cardinal Health
Oct 31, 2025
Maintains: Outperform
Price Target: $190 → $220
Current: $202.95
Upside: +8.40%
Teladoc Health
Oct 30, 2025
Maintains: In-Line
Price Target: $9 → $8
Current: $7.23
Upside: +10.65%
CVS Health
Oct 30, 2025
Maintains: Outperform
Price Target: $85 → $95
Current: $77.72
Upside: +22.23%
Align Technology
Oct 30, 2025
Maintains: Outperform
Price Target: $160 → $170
Current: $157.69
Upside: +7.81%
DENTSPLY SIRONA
Oct 8, 2025
Maintains: In-Line
Price Target: $17 → $13
Current: $11.21
Upside: +15.97%
IQVIA Holdings
Oct 8, 2025
Maintains: Outperform
Price Target: $220 → $240
Current: $220.69
Upside: +8.75%
Oct 8, 2025
Maintains: Outperform
Price Target: $60 → $65
Current: $47.25
Upside: +37.57%
Oct 8, 2025
Maintains: In-Line
Price Target: $4 → $3
Current: $2.35
Upside: +27.66%
Oct 8, 2025
Maintains: In-Line
Price Target: $7 → $11
Current: $17.74
Upside: -37.99%
Oct 8, 2025
Maintains: In-Line
Price Target: $185 → $190
Current: $176.06
Upside: +7.92%
Oct 3, 2025
Maintains: Outperform
Price Target: $300 → $305
Current: $252.03
Upside: +21.02%
Sep 24, 2025
Maintains: Outperform
Price Target: $800 → $825
Current: $820.25
Upside: +0.58%
Jul 9, 2025
Maintains: Outperform
Price Target: $19 → $23
Current: $22.28
Upside: +3.23%
Jul 9, 2025
Maintains: In-Line
Price Target: $5 → $3
Current: $0.73
Upside: +308.44%
Nov 7, 2024
Maintains: Outperform
Price Target: $32 → $36
Current: $32.84
Upside: +9.62%
Mar 16, 2022
Maintains: In-Line
Price Target: $68 → $26
Current: $2.33
Upside: +1,026.61%
Mar 2, 2022
Downgrades: In-Line
Price Target: $35 → $15
Current: $4.37
Upside: +243.25%
Jan 4, 2022
Downgrades: In-Line
Price Target: $11
Current: $1.33
Upside: +727.07%